Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
delayed addition of BIO-acetoxime (BIA) also inhibits HSV-1 infection
PubMed PMID: 31525930
Coffman KJ
43(9):1871-1879
α2-adrenergic (pKi = 7
Apremilast - CAS# 608141-41-9 Size:Solid 10 mg delayed addition of BIO-acetoxime (BIA)Apremilast, also known as CC 10004, is a thalidomide analog and is an orally available small molecule inhibitor of phosphodiesterase 4 (PDE4). Apremilast specifically inhibits PDE4 and inhibits spontaneous production of TNF alpha from human rheumatoid synovial cells. It has anti inflammatory activity. Apremilast was approved by the USFDA in March 2014 for treatment of adults with active psoriatic arthritis. It is also being tested for its efficacy in
US$ 26.00
US$ 44.95
US$ 20.00
US$ 63.00
US$ 20.00
US$ 39.00